Specific Biologics
specificbiologics.com
Health Care
Biologics & Biosimilars
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Seed
Dec 2021 · 4 yr ago
Backers
1
Lumira Ventures
The money's age
Long since its last round
58 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 11, 2025
Board appointment Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors · CNWGroup
Dec 16, 2021
Raised a round Seed · led by Lumira Ventures · CNWGroup
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Dec 2021 | — | Lumira Ventures lead | CNWGroup |
Backed byfrom the funds' portfolios and accelerator catalogs
Lumira Ventures News
Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company
/PRNewswire/ - Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the...
Read more
Report
Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of ...
Read more
Report
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
/PRNewswire/ - Specific Biologics Inc. ("Specific Biologics"), a precision in vivo genome editing company developing highly predictable, efficient and specific...
Read more
Report
Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors
Specific Biologics Inc., a biotechnology company advancing Dualase genome editors for precise and programmable in vivo genome editing, today announced the appointment of Paul J. Hastings as Chair of its Board of Directors.
Read more
Report
Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors
/CNW/ - Specific Biologics Inc., a biotechnology company advancing Dualase genome editors for precise and programmable in vivo genome editing, today announced...
Read more
Report
Specific Biologics Inc. to Present Dualase Genome Editing for the Precise Removal of Pathogenic Repeats in Repeat Expansion Disorders at the 28th Annual American Society for Gene and Cell Therapy Meeting
/CNW/ - Specific Biologics Inc., a biotechnology company advancing industry leading genome editing therapies, today announced it will present new preclinical...
Read more
Report
Specific Biologics Inc. to Present Dualase(R) Genome Editing for the Precise Removal of Pathogenic Repeats in Repeat Expansion Disorders at the 28th Annual American Society for ...
Read more
Report
Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors
Dr. Kanner joins Brent Stead, PhD, MBA, as well as seasoned company builders Daniel Hétu, MD, MBA of Lumira Ventures, Nikhil Thatte, B.Eng of Lumira Ventures and Frédéric Lemaître Auger, MSc, PhD, MBA of adMare BioInnovations. The appointment coincides wi
Read more
Report
Specific Biologics Strengthens Scientific Advisory Board with Appointment of Tirtha Chakraborty, Ph.D. and Mike Nicholson, Ph.D.
/PRNewswire/ - Specific Biologics Inc. ("Specific"), a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Tirtha...
Read more
Report
Specific Biologics Closes Seed Financing with Industry Leaders Lumira Ventures and adMare BioInnovations
/CNW/ - Specific Biologics Inc. ("Specific") today announced that it has closed its first institutional financing, led by Lumira Ventures and adMare...
Read more
Report
Show more news
Financials
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2021 | — | Details |